You are here

Article info

Article menu

Download PDFPDF

Communication
Severe SARS-CoV-2 infection: does the artificial sweetener sucralose play a role?

Authors

  • Susan S Schiffman Biomedical Engineering, North Carolina State University at Raleigh, Raleigh, North Carolina, USA PubMed articlesGoogle scholar articles
  • H Troy Nagle Biomedical Engineering, North Carolina State University at Raleigh, Raleigh, North Carolina, USAElectrical and Computer Engineering, North Carolina State University at Raleigh, Raleigh, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Susan S Schiffman; schiffmansusan{at}gmail.com
View Full Text

Citation

Schiffman SS, Nagle HT
Severe SARS-CoV-2 infection: does the artificial sweetener sucralose play a role?
BMJ Open Gastroenterology 2023;10:e001159. doi: 10.1136/bmjgast-2023-001159

Publication history

  • First published May 12, 2023.
Online issue publication 
February 12, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.